Skip to main content
TA

Tallac Therapeutics

Burlingame, United States
Last funding
$5.0M
Debt FinancingAug 2023

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

Backed byMatrix Partners ChinavenBio PartnersLightstone VenturesHorizon Technology FinanceMRL Ventures Fund

About Tallac Therapeutics

How much funding has Tallac Therapeutics raised?

Tallac Therapeutics has raised $5.0M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2023.

Who are Tallac Therapeutics's investors?

Tallac Therapeutics's investors include Matrix Partners China, venBio Partners, Lightstone Ventures, Horizon Technology Finance, MRL Ventures Fund.

Where is Tallac Therapeutics headquartered?

Tallac Therapeutics is headquartered in Burlingame, United States.

What does Tallac Therapeutics do?

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

What stage is Tallac Therapeutics at?

Tallac Therapeutics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Tallac Therapeutics — Funding & Investors." VCBacked, August 2, 2023, https://www.vcbacked.co/company/tallac-therapeutics. Accessed November 15, 2026.
APA
VCBacked. (2023). Tallac Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/tallac-therapeutics
Wikipedia (cite web)
{{cite web |title=Tallac Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tallac-therapeutics |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Tallac Therapeutics? Request a listing update

Founder contacts
m***@tallactherapeutics.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →